Grafa News and Videos — Page 287

Mesoblast (NASDAQ:MESO) reported preliminary Ryoncil® net revenue of $36 million for the June 2026 quarter, bringing first-year post-FDA approval revenue to $115 million.

ING Groep (NYSE:ING) reported a second-quarter 2026 net result of €1.9 billion, up 23% year over year, supported by higher interest and fee income.

ArcelorMittal (NYSE:MT) reported second-quarter 2026 sales of $16.8 billion, up 8.4% quarter over quarter, with EBITDA of $2.1 billion as margins improved.

Pharming (NASDAQ:PHAR) reported preliminary second-quarter 2026 revenue of $90.2 million, down 3% year over year, as lower RUCONEST sales offset growth from Joenja.

Anheuser-Busch InBev (NYSE:BUD) reported second-quarter 2026 reported revenue of $16.7 billion, up 11%, with underlying revenue growth of 5.6% driven by higher revenue per hectoliter and volume growth.

The Magnum Ice Cream Company (NYSE:MICC) reported first-half 2026 revenue of €4.7 billion, up from €4.5 billion a year earlier, driven by 4.7% organic sales growth across all regions.

Stellantis (NYSE:STLA) reported second-quarter 2026 net revenues of €43.5 billion, up 13% year over year, as growth in North America and South America supported higher sales.

ASE Technology Holding (NYSE:ASX) reported second-quarter 2026 revenue of NT$191.1 billion, up 26.7% year over year, as higher semiconductor packaging and testing demand lifted results.

Telegram is facing legal action in Australia over allegations it failed to remove extremist and terrorist content from its messaging platform.

Takeda Pharmaceutical (NYSE:TAK) reported first-quarter revenue of ¥1.22 trillion, up 10.2%, as core brands offset weaker VYVANSE sales.